Neuroleptic syndrome among patients receiving antipsychotic drugs-review

Neuroleptic Malignant Syndrome is occasional but deadly reaction, which results from treatment with antipsychotic medications. Risk aspects include the following: dehydration, agitation, and history of neuroleptic malignant syndrome.  Despite the fact that Neuroleptic Malignant Syndrome has been des...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Yuabova, Marina
Formato: Online
Idioma:por
Publicado em: FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE, BRAZIL
Endereço do item:https://periodicos.ufrn.br/jscr/article/view/8629
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
id oai:periodicos.ufrn.br:article-8629
record_format ojs
spelling oai:periodicos.ufrn.br:article-86292019-06-05T23:31:04Z Neuroleptic syndrome among patients receiving antipsychotic drugs-review Yuabova, Marina Neuroleptic syndrome Antipsychotic drugs Diagnostic criteria Side effects Mental Illness Neuroleptic Malignant Syndrome is occasional but deadly reaction, which results from treatment with antipsychotic medications. Risk aspects include the following: dehydration, agitation, and history of neuroleptic malignant syndrome.  Despite the fact that Neuroleptic Malignant Syndrome has been described as adverse effect from treatment with antipsychotic medications, patients suffering with chemical imbalance of brain or mood disorders, especially when treated with lithium, fall in to higher risk group. Standard criteria for the diagnosis of Neuroleptic Malignant Syndrome highlight the following signs and symptoms: muscle rigidity, hyperthermia, alteration in mental status, and autonomic dysfunction.  Syndrome usually lasts from 7 to 10 days in simple and uncomplicated patients who receiving neuroleptics orally.  Early detection and diagnosis of syndrome are up the most importance, where discontinuance of triggering medication, managing of fluid balance, control of body temperature and close observation for complications takes place.  Use of dopamine agonists should be advised in more complex cases.  Electroconvulsive therapy has also been effective in a few cases.  In this article author reviews the proposed pathology, symptoms, complications, and treatment of Neuroleptic malignant syndrome FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE, BRAZIL 2016-02-16 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion application/pdf https://periodicos.ufrn.br/jscr/article/view/8629 JOURNAL OF SURGICAL AND CLINICAL RESEARCH; Vol. 6 No. 2 (2015); 64-72 JOURNAL OF SURGICAL AND CLINICAL RESEARCH; v. 6 n. 2 (2015); 64-72 2179-7889 por https://periodicos.ufrn.br/jscr/article/view/8629/6213 Copyright (c) 2016 JOURNAL OF SURGICAL AND CLINICAL RESEARCH
institution Periódicos UFRN
collection Portal de Pediódicos Eletrônicos da UFRN
language por
format Online
author Yuabova, Marina
spellingShingle Yuabova, Marina
Neuroleptic syndrome among patients receiving antipsychotic drugs-review
author_facet Yuabova, Marina
author_sort Yuabova, Marina
title Neuroleptic syndrome among patients receiving antipsychotic drugs-review
title_short Neuroleptic syndrome among patients receiving antipsychotic drugs-review
title_full Neuroleptic syndrome among patients receiving antipsychotic drugs-review
title_fullStr Neuroleptic syndrome among patients receiving antipsychotic drugs-review
title_full_unstemmed Neuroleptic syndrome among patients receiving antipsychotic drugs-review
title_sort neuroleptic syndrome among patients receiving antipsychotic drugs-review
description Neuroleptic Malignant Syndrome is occasional but deadly reaction, which results from treatment with antipsychotic medications. Risk aspects include the following: dehydration, agitation, and history of neuroleptic malignant syndrome.  Despite the fact that Neuroleptic Malignant Syndrome has been described as adverse effect from treatment with antipsychotic medications, patients suffering with chemical imbalance of brain or mood disorders, especially when treated with lithium, fall in to higher risk group. Standard criteria for the diagnosis of Neuroleptic Malignant Syndrome highlight the following signs and symptoms: muscle rigidity, hyperthermia, alteration in mental status, and autonomic dysfunction.  Syndrome usually lasts from 7 to 10 days in simple and uncomplicated patients who receiving neuroleptics orally.  Early detection and diagnosis of syndrome are up the most importance, where discontinuance of triggering medication, managing of fluid balance, control of body temperature and close observation for complications takes place.  Use of dopamine agonists should be advised in more complex cases.  Electroconvulsive therapy has also been effective in a few cases.  In this article author reviews the proposed pathology, symptoms, complications, and treatment of Neuroleptic malignant syndrome
publisher FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE, BRAZIL
publishDate 2016
url https://periodicos.ufrn.br/jscr/article/view/8629
work_keys_str_mv AT yuabovamarina neurolepticsyndromeamongpatientsreceivingantipsychoticdrugsreview
_version_ 1766682140484829184

Registros relacionados